GlassScriptPhysician profile
Emil MD Ganjian
NPI 1902824782
$1,853.19
in general payments reported to CMS, 2019-2025
7 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $149 · 2021: $339 · 2022: $302 · 2023: $754 · 2024: $175 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $779.11 | 2023-2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Intersect Ent, INC. | $309.83 | 2020-2022 | |
| Acclarent, INC | $183.77 | 2021-2022 | |
| Stryker Corporation | $175.52 | 2021-2022 | |
| Inspire Medical Systems, INC. | $150.10 | 2023 | Inspire |
| Integra Lifesciences Corporation | $133.33 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Optinose US, INC. | $121.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emil Ganjian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.